UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery

Advanced drug delivery reviews, 2018-04, Vol.129, p.37-53

2018

Volltextzugriff (PDF)

The role of liposomes in clinical nanomedicine development. What now? Now what?

Journal of controlled release, 2020-02, Vol.318, p.256-263

2020

Volltextzugriff (PDF)

Targeting the Stat6 pathway in tumor‐associated macrophages reduces tumor growth and metastatic niche formation in breast cancer

The FASEB journal, 2018-02, Vol.32 (2), p.969-978

2018

Volltextzugriff (PDF)

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization

Frontiers in pharmacology, 2018-07, Vol.9, p.790-790

2018

Volltextzugriff (PDF)

Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities

Journal of controlled release, 2018-05, Vol.277, p.1-13

2018

Volltextzugriff (PDF)

Nanomedicine Strategies to Target Tumor-Associated Macrophages

International journal of molecular sciences, 2017-05, Vol.18 (5), p.979

2017

Volltextzugriff (PDF)

Dexamethasone nanomedicines for COVID-19

Nature nanotechnology, 2020-08, Vol.15 (8), p.622-624

2020

Volltextzugriff (PDF)

Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo

Journal of controlled release, 2021-09, Vol.337, p.521-529

2021

Volltextzugriff (PDF)

Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors

Advanced drug delivery reviews, 2017-09, Vol.119, p.44-60

2017

Volltextzugriff (PDF)

Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines

Nature nanotechnology, 2022-04, Vol.17 (4), p.337-346

2022

Volltextzugriff (PDF)

Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges

International journal of pharmaceutics, 2016-02, Vol.499 (1-2), p.358-367

2016

Volltextzugriff (PDF)

Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status

Advanced drug delivery reviews, 2013-10, Vol.65 (10), p.1284-1298

2013

Volltextzugriff (PDF)

Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement

Journal of controlled release, 2022-01, Vol.341, p.475-486

2022

Volltextzugriff (PDF)

Cancer nanomedicine: is targeting our target?

Nature reviews. Materials, 2016-09, Vol.1 (9), Article 16069

2016

Volltextzugriff (PDF)

Nanotheranostics and Image-Guided Drug Delivery: Current Concepts and Future Directions

Molecular pharmaceutics, 2010-12, Vol.7 (6), p.1899-1912

2010

Volltextzugriff (PDF)

Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines

Nano letters, 2014-02, Vol.14 (2), p.972-981

2014

Volltextzugriff (PDF)

Tumor stroma-containing 3D spheroid arrays: A tool to study nanoparticle penetration

Journal of controlled release, 2016-12, Vol.244 (Pt B), p.257-268

2016

Volltextzugriff (PDF)

Duration of ultrasound-mediated enhanced plasma membrane permeability

International journal of pharmaceutics, 2015-03, Vol.482 (1-2), p.92-98

2015

Volltextzugriff (PDF)

Targeting tumor antigens to dendritic cells using particulate carriers

Journal of controlled release, 2012-07, Vol.161 (1), p.25-37

2012

Volltextzugriff (PDF)

MicroRNA Targeting to Modulate Tumor Microenvironment

Frontiers in oncology, 2016-01, Vol.6, p.3-3

2016

Volltextzugriff (PDF)

Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl4-induced liver fibrogenesis mouse model

Scientific reports, 2017-03, Vol.7 (1), p.44545-44545, Article 44545

2017

Volltextzugriff (PDF)

Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles

Biomaterials, 2017-01, Vol.114, p.106-120

2017

Volltextzugriff (PDF)

Differential uptake of nanoparticles by human M1 and M2 polarized macrophages: protein corona as a critical determinant

Nanomedicine (London, England), 2016-11, Vol.11 (22), p.2889-2902

2016

Volltextzugriff (PDF)

Cancer immune therapy using engineered ‛tail-flipping’ nanoliposomes targeting alternatively activated macrophages

Nature communications, 2022-08, Vol.13 (1), p.4548-4548, Article 4548

2022

Volltextzugriff (PDF)

Cancer nanomedicine meets immunotherapy: opportunities and challenges

Acta pharmacologica Sinica, 2020-07, Vol.41 (7), p.954-958

2020

Volltextzugriff (PDF)

1 – 25 von 547

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(522)
Mit Volltextzugriff
(489)

Publikationsform

Sprache

Englisch
(547)
Japanisch
(90)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(438)
Life Sciences & Biomedicine
(365)
Animals
(259)
Pharmacology & Pharmacy
(224)
Humans
(221)
Liposomes
(161)
Physical Sciences
(137)
Chemistry
(131)
Biological And Medical Sciences
(130)
Mice
(127)
Medical Sciences
(126)
Chemistry, Multidisciplinary
(122)
Pharmacology. Drug Treatments
(106)
Drug Delivery Systems
(87)
General Pharmacology
(86)
Male
(86)
Pharmaceutical Technology. Pharmaceutical Industry
(86)
Nanomedicine
(72)
Female
(67)
Biochemistry & Molecular Biology
(66)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery

The role of liposomes in clinical nanomedicine development. What now? Now what?

Targeting the Stat6 pathway in tumor‐associated macrophages reduces tumor growth and metastatic niche formation in breast cancer

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization

Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities

Nanomedicine Strategies to Target Tumor-Associated Macrophages

Dexamethasone nanomedicines for COVID-19

Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo

Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors

Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines

Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges

Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status

Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement

Cancer nanomedicine: is targeting our target?

Nanotheranostics and Image-Guided Drug Delivery: Current Concepts and Future Directions

Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines

Tumor stroma-containing 3D spheroid arrays: A tool to study nanoparticle penetration

Duration of ultrasound-mediated enhanced plasma membrane permeability

Targeting tumor antigens to dendritic cells using particulate carriers

MicroRNA Targeting to Modulate Tumor Microenvironment

Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl4-induced liver fibrogenesis mouse model

Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles

Differential uptake of nanoparticles by human M1 and M2 polarized macrophages: protein corona as a critical determinant

Cancer immune therapy using engineered ‛tail-flipping’ nanoliposomes targeting alternatively activated macrophages

Cancer nanomedicine meets immunotherapy: opportunities and challenges

Suchergebnisse filtern